CN100368402C - 奥硝唑光学对映体的制备方法 - Google Patents
奥硝唑光学对映体的制备方法 Download PDFInfo
- Publication number
- CN100368402C CN100368402C CNB2006100864150A CN200610086415A CN100368402C CN 100368402 C CN100368402 C CN 100368402C CN B2006100864150 A CNB2006100864150 A CN B2006100864150A CN 200610086415 A CN200610086415 A CN 200610086415A CN 100368402 C CN100368402 C CN 100368402C
- Authority
- CN
- China
- Prior art keywords
- preparation
- organic solvent
- ornidazole
- reaction
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000003287 optical effect Effects 0.000 title claims abstract description 11
- 238000002360 preparation method Methods 0.000 title claims description 29
- 239000003960 organic solvent Substances 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims abstract description 9
- 239000002841 Lewis acid Substances 0.000 claims abstract description 7
- 150000007517 lewis acids Chemical class 0.000 claims abstract description 7
- 229960002313 ornidazole Drugs 0.000 claims description 32
- 238000006243 chemical reaction Methods 0.000 claims description 26
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 24
- 239000000243 solution Substances 0.000 claims description 14
- IPWKIXLWTCNBKN-UHFFFAOYSA-N Madelen Chemical compound CC1=NC=C([N+]([O-])=O)N1CC(O)CCl IPWKIXLWTCNBKN-UHFFFAOYSA-N 0.000 claims description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 11
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 10
- FFYTTYVSDVWNMY-UHFFFAOYSA-N 2-Methyl-5-nitroimidazole Chemical class CC1=NC=C([N+]([O-])=O)N1 FFYTTYVSDVWNMY-UHFFFAOYSA-N 0.000 claims description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 8
- 239000007864 aqueous solution Substances 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- LRWZZZWJMFNZIK-NFJMKROFSA-N (2R)-2-chloro-3-methyloxirane Chemical compound CC1O[C@@H]1Cl LRWZZZWJMFNZIK-NFJMKROFSA-N 0.000 claims description 7
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 7
- 239000002585 base Substances 0.000 claims description 7
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 239000011259 mixed solution Substances 0.000 claims description 6
- 238000001953 recrystallisation Methods 0.000 claims description 6
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 4
- 239000012043 crude product Substances 0.000 claims description 4
- 230000035484 reaction time Effects 0.000 claims description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 3
- 238000006555 catalytic reaction Methods 0.000 claims description 3
- 235000005074 zinc chloride Nutrition 0.000 claims description 3
- 239000011592 zinc chloride Substances 0.000 claims description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 2
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- 239000012044 organic layer Substances 0.000 claims description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 claims description 2
- 235000011152 sodium sulphate Nutrition 0.000 claims description 2
- 239000002994 raw material Substances 0.000 abstract description 5
- 229960004918 nimorazole Drugs 0.000 abstract 3
- BRLQWZUYTZBJKN-VKHMYHEASA-N (-)-Epichlorohydrin Chemical compound ClC[C@H]1CO1 BRLQWZUYTZBJKN-VKHMYHEASA-N 0.000 abstract 1
- MDJFHRLTPRPZLY-UHFFFAOYSA-N nimorazole Chemical compound [O-][N+](=O)C1=CN=CN1CCN1CCOCC1 MDJFHRLTPRPZLY-UHFFFAOYSA-N 0.000 abstract 1
- 238000003756 stirring Methods 0.000 description 5
- 238000002425 crystallisation Methods 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- 239000002168 alkylating agent Substances 0.000 description 2
- 229940100198 alkylating agent Drugs 0.000 description 2
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- AIDLAEPHWROGFI-UHFFFAOYSA-N 2-methylbenzene-1,3-dicarboxylic acid Chemical compound CC1=C(C(O)=O)C=CC=C1C(O)=O AIDLAEPHWROGFI-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 230000000842 anti-protozoal effect Effects 0.000 description 1
- 239000003904 antiprotozoal agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (15)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100864150A CN100368402C (zh) | 2005-11-16 | 2006-06-19 | 奥硝唑光学对映体的制备方法 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200510115361.1 | 2005-11-16 | ||
CN200510115361 | 2005-11-16 | ||
CNB2006100864150A CN100368402C (zh) | 2005-11-16 | 2006-06-19 | 奥硝唑光学对映体的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1923817A CN1923817A (zh) | 2007-03-07 |
CN100368402C true CN100368402C (zh) | 2008-02-13 |
Family
ID=37816659
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100864150A Active CN100368402C (zh) | 2005-11-16 | 2006-06-19 | 奥硝唑光学对映体的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100368402C (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101817786A (zh) * | 2010-04-13 | 2010-09-01 | 陕西合成药业有限公司 | 一种左旋奥硝唑的制备方法 |
CN102643238B (zh) * | 2012-04-06 | 2016-05-11 | 陕西合成药业股份有限公司 | 一种新的奥硝唑光学对映体的制备及其纯化方法 |
CN105585532B (zh) * | 2014-10-24 | 2018-05-01 | 山东齐都药业有限公司 | 左奥硝唑反应液的后处理方法 |
CN105777648A (zh) * | 2014-12-22 | 2016-07-20 | 山东齐都药业有限公司 | 左奥硝唑α晶型及其制备方法 |
CN105037272B (zh) * | 2015-06-30 | 2017-04-19 | 湖南三清药业有限公司 | 左奥硝唑化合物及其药物组合物 |
CN112125851A (zh) * | 2020-08-28 | 2020-12-25 | 石家庄四药有限公司 | 一种光学活性奥硝唑的制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3435049A (en) * | 1965-05-19 | 1969-03-25 | Hoffmann La Roche | Nitroimidazole derivatives |
WO1994015922A1 (en) * | 1992-07-31 | 1994-07-21 | Warner Lambert Company | Novel process for preparing chiral [[(2-bromoethyl)amino]methyl]-2-nitro-1h-imidazol-1-ethanol and related compounds |
CN1400312A (zh) * | 2002-08-23 | 2003-03-05 | 中国科学院上海有机化学研究所 | 外消旋奥硝唑的酶法拆分方法 |
CN1651415A (zh) * | 2004-11-29 | 2005-08-10 | 南京圣和药业有限公司 | 奥硝唑光学对映体的制备及纯化方法 |
-
2006
- 2006-06-19 CN CNB2006100864150A patent/CN100368402C/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3435049A (en) * | 1965-05-19 | 1969-03-25 | Hoffmann La Roche | Nitroimidazole derivatives |
DE1695139A1 (de) * | 1965-05-19 | 1970-12-17 | Hoffmann La Roche | Verfahren zur Herstellung von Imidazolderivaten |
WO1994015922A1 (en) * | 1992-07-31 | 1994-07-21 | Warner Lambert Company | Novel process for preparing chiral [[(2-bromoethyl)amino]methyl]-2-nitro-1h-imidazol-1-ethanol and related compounds |
US5342959A (en) * | 1992-07-31 | 1994-08-30 | Warner-Lambert Company | Process for preparing chiral [[(2-bromoethyl)-amino]methyl]-2-nitro-1H-imidazol-1-ethanol and related compounds |
CN1400312A (zh) * | 2002-08-23 | 2003-03-05 | 中国科学院上海有机化学研究所 | 外消旋奥硝唑的酶法拆分方法 |
CN1651415A (zh) * | 2004-11-29 | 2005-08-10 | 南京圣和药业有限公司 | 奥硝唑光学对映体的制备及纯化方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1923817A (zh) | 2007-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100368402C (zh) | 奥硝唑光学对映体的制备方法 | |
CN101657462B (zh) | 卡培他滨的制备方法及其中间体 | |
CN103664697B (zh) | 用于制备芳香族环丙腈及环丙胺的化学方法 | |
CN112062712A (zh) | 一种2-(5-溴-3-甲基吡啶-2-基)乙酸盐酸盐的制备方法 | |
CN104945332A (zh) | 埃罗替尼的制备方法 | |
CN103483324A (zh) | 拉帕替尼的新制备方法 | |
CN104837813A (zh) | 氨基甲酸酯化合物的制造方法 | |
CN104159884B (zh) | 通过使用水或多种酸作为添加剂的新型麦克尔加成反应制备化合物的方法 | |
CN106083759B (zh) | 一种芦曲泊帕的全新合成工艺 | |
CN110669002B (zh) | 一种2-氟-3-羟基吡啶-4-羧酸的合成方法 | |
CN100406568C (zh) | 氯吡格雷新生产工艺 | |
CN101891731B (zh) | 一种奥洛他定e构型异构体的合成方法 | |
CN100516039C (zh) | 大规模制备维甲酰酚胺类化合物的方法 | |
CN105669634B (zh) | 一种罗丹明110的制备方法 | |
CN109160886B (zh) | 一种n-苯基苯甲酰胺合成方法 | |
CN103787968A (zh) | 化合物的制备方法 | |
CN108727428B (zh) | β-氨基膦酸衍生物及其制备方法 | |
WO2013062294A2 (ko) | 미티글리나이드 칼슘염의 개선된 제조방법 | |
KR101435741B1 (ko) | 신규한 보리코나졸 중간체 및 이를 이용한 보리코나졸의 제조 방법 | |
WO2020010586A1 (zh) | β-氨基膦酸衍生物及其制备方法 | |
CN102898373B (zh) | Z-3-酰氧基-3-(1-乙基吡唑基)丙烯腈类化合物的制备方法 | |
CN113004161B (zh) | 一种(2r,3r)-3-甲基-3-苯基丙氨酸的制备方法 | |
CN101397278B (zh) | 一种3-芳基-5-烯基噁唑啉-2-酮的合成方法 | |
CN113801062B (zh) | 3-氨基-5-(3,5-二氟苄基)-1h-吲唑的制备方法 | |
KR100968576B1 (ko) | 2-아실-3-아미노-2-알케노에이트의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Zhejiang Starry Pharmaceutical Co.,Ltd. Assignor: J&HEALTH BIOTECHNOLOGY CO.,LTD.|CHANGSHA HUAMEI MEDICINE Research Institute Contract fulfillment period: 2008.8.24 to 2026.6.18 Contract record no.: 2009330001213 Denomination of invention: Preparation method for optical enantiomer of ornidaxole Granted publication date: 20080213 License type: Exclusive license Record date: 20090526 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2008.8.24 TO 2026.6.18; CHANGE OF CONTRACT Name of requester: ZHEJIANG STARRY PHARMACEUTICAL CO., LTD Effective date: 20090526 |
|
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Zhejiang Starry Pharmaceutical Co.,Ltd. Assignor: J&HEALTH BIOTECHNOLOGY CO.,LTD.|CHANGSHA HUAMEI MEDICINE Research Institute Contract record no.: 2009330001213 Date of cancellation: 20140113 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: South Street in Dongling District of Shenyang city in Liaoning province 110016 129 Lane 28 Building No. 2 Co-patentee after: CHANGSHA HUAMEI MEDICINE SCIENCE & TECHNOLOGY Co.,Ltd. Patentee after: J&HEALTH BIOTECHNOLOGY CO.,LTD. Address before: South Street in Dongling District of Shenyang city in Liaoning province 110016 129 Lane 28 Building No. 2 Co-patentee before: Changsha Huamei Medicine Research Institute Patentee before: J&HEALTH BIOTECHNOLOGY CO.,LTD. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190815 Address after: 410329 Liuyang Biomedical Park, Changsha City, Hunan Province Co-patentee after: CHANGSHA HUAMEI MEDICINE SCIENCE & TECHNOLOGY Co.,Ltd. Patentee after: HUNAN WARRANT PHARMACEUTICAL Co.,Ltd. Address before: South Street in Dongling District of Shenyang city in Liaoning province 110016 129 Lane 28 Building No. 2 Co-patentee before: CHANGSHA HUAMEI MEDICINE SCIENCE & TECHNOLOGY Co.,Ltd. Patentee before: J&HEALTH BIOTECHNOLOGY CO.,LTD. |